HomeBXP • LON
add
Beximco Pharmaceuticals GDR
Previous close
GBX 31.00
Day range
GBX 31.77 - GBX 32.00
Year range
GBX 19.33 - GBX 45.00
Avg Volume
63.92K
In the news
Financials
Income Statement
Revenue
Net income
| (BDT) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 11.71B | 4.97% |
Operating expense | 2.96B | 10.47% |
Net income | 1.68B | 8.22% |
Net profit margin | 14.35 | 3.09% |
Earnings per share | — | — |
EBITDA | 2.87B | 6.45% |
Effective tax rate | 22.88% | — |
Balance Sheet
Total assets
Total liabilities
| (BDT) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.31B | -15.01% |
Total assets | 70.90B | 2.23% |
Total liabilities | 17.30B | -14.19% |
Total equity | 53.60B | — |
Shares outstanding | 445.77M | — |
Price to book | 0.00 | — |
Return on assets | 8.74% | — |
Return on capital | 10.53% | — |
Cash Flow
Net change in cash
| (BDT) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 1.68B | 8.22% |
Cash from operations | 1.70B | -37.34% |
Cash from investing | -576.06M | 28.64% |
Cash from financing | -1.12B | 46.49% |
Net change in cash | 5.26M | 102.74% |
Free cash flow | -53.70M | — |
About
Founded
1976
Headquarters
Website
Employees
1,122
